Harvest Fund Management Co., LTD Crinetics Pharmaceuticals, Inc. Transaction History
Harvest Fund Management Co., LTD
- $2.14 Billion
- Q4 2024
A detailed history of Harvest Fund Management Co., LTD transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, Harvest Fund Management Co., LTD holds 1,299 shares of CRNX stock, worth $48,660. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,299Holding current value
$48,660% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CRNX
# of Institutions
254Shares Held
89.2MCall Options Held
26.1KPut Options Held
11.8K-
Vanguard Group Inc Valley Forge, PA9.09MShares$340 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA6.95MShares$260 Million0.07% of portfolio
-
Black Rock Inc. New York, NY6.23MShares$233 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.14MShares$230 Million3.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.41MShares$203 Million0.03% of portfolio
About Crinetics Pharmaceuticals, Inc.
- Ticker CRNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,752,800
- Market Cap $2.01B
- Description
- Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...